156 related articles for article (PubMed ID: 26956920)
1. Strategies for meloxicam delivery to and across the skin: a review.
Chen J; Gao Y
Drug Deliv; 2016 Oct; 23(8):3146-3156. PubMed ID: 26956920
[TBL] [Abstract][Full Text] [Related]
2. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization.
Ah YC; Choi JK; Choi YK; Ki HM; Bae JH
Int J Pharm; 2010 Jan; 385(1-2):12-9. PubMed ID: 19833177
[TBL] [Abstract][Full Text] [Related]
3. Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation.
Khurana S; Jain NK; Bedi PM
Drug Dev Ind Pharm; 2015; 41(8):1368-75. PubMed ID: 25151872
[TBL] [Abstract][Full Text] [Related]
4. Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery.
El-Menshawe SF; Hussein AK
Pharm Dev Technol; 2013; 18(4):779-86. PubMed ID: 21913880
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers.
Duangjit S; Opanasopit P; Rojanarata T; Ngawhirunpat T
AAPS PharmSciTech; 2013 Mar; 14(1):133-40. PubMed ID: 23242556
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of novel ultradeformable liposomes: menthosomes, transfersomes and liposomes for enhancing skin permeation of meloxicam.
Duangjit S; Obata Y; Sano H; Onuki Y; Opanasopit P; Ngawhirunpat T; Miyoshi T; Kato S; Takayama K
Biol Pharm Bull; 2014; 37(2):239-47. PubMed ID: 24225259
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
Khurana S; Jain NK; Bedi PM
Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
[TBL] [Abstract][Full Text] [Related]
8. Formulation of meloxicam gel for topical application: In vitro and in vivo evaluation.
Bachhav YG; Patravale VB
Acta Pharm; 2010 Jun; 60(2):153-63. PubMed ID: 21134852
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam.
Khurana S; Bedi PM; Jain NK
Chem Phys Lipids; 2013; 175-176():65-72. PubMed ID: 23994283
[TBL] [Abstract][Full Text] [Related]
10. Menthosomes, novel ultradeformable vesicles for transdermal drug delivery: optimization and characterization.
Duangjit S; Obata Y; Sano H; Kikuchi S; Onuki Y; Opanasopit P; Ngawhirunpat T; Maitani Y; Takayama K
Biol Pharm Bull; 2012; 35(10):1720-8. PubMed ID: 23037161
[TBL] [Abstract][Full Text] [Related]
11. Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation.
Khurana S; Jain NK; Bedi PM
Life Sci; 2013 Mar; 92(6-7):383-92. PubMed ID: 23353874
[TBL] [Abstract][Full Text] [Related]
12. Design of meloxicam and lornoxicam transdermal patches: Preparation, physical characterization, ex vivo and in vivo studies.
Yener G; Üner M; Gönüllü Ü; Yildirim S; Kiliç P; Aslan SS; Barla A
Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1466-73. PubMed ID: 21048338
[TBL] [Abstract][Full Text] [Related]
13. Cyclodextrin-based oral dissolving films formulation of taste-masked meloxicam.
Samprasit W; Akkaramongkolporn P; Kaomongkolgit R; Opanasopit P
Pharm Dev Technol; 2018 Jun; 23(5):530-539. PubMed ID: 29103353
[TBL] [Abstract][Full Text] [Related]
14. Role of the charge, carbon chain length, and content of surfactant on the skin penetration of meloxicam-loaded liposomes.
Duangjit S; Pamornpathomkul B; Opanasopit P; Rojanarata T; Obata Y; Takayama K; Ngawhirunpat T
Int J Nanomedicine; 2014; 9():2005-17. PubMed ID: 24851047
[TBL] [Abstract][Full Text] [Related]
15. Bovine serum albumin-meloxicam nanoaggregates laden contact lenses for ophthalmic drug delivery in treatment of postcataract endophthalmitis.
Zhang W; Zu D; Chen J; Peng J; Liu Y; Zhang H; Li S; Pan W
Int J Pharm; 2014 Nov; 475(1-2):25-34. PubMed ID: 25158220
[TBL] [Abstract][Full Text] [Related]
16. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
[TBL] [Abstract][Full Text] [Related]
17. Development of meloxicam in situ implant formulation by quality by design principle.
Ibrahim HM; Ahmed TA; Hussain MD; Rahman Z; Samy AM; Kaseem AA; Nutan MT
Drug Dev Ind Pharm; 2014 Jan; 40(1):66-73. PubMed ID: 23298324
[TBL] [Abstract][Full Text] [Related]
18. Effect of solubility enhancement on nasal absorption of meloxicam.
Horváth T; Ambrus R; Völgyi G; Budai-Szűcs M; Márki Á; Sipos P; Bartos C; Seres AB; Sztojkov-Ivanov A; Takács-Novák K; Csányi E; Gáspár R; Szabó-Révész P
Eur J Pharm Sci; 2016 Dec; 95():96-102. PubMed ID: 27260088
[TBL] [Abstract][Full Text] [Related]
19. Ion-pair formation combined with a penetration enhancer as a dual strategy to improve the transdermal delivery of meloxicam.
Jiang Q; Wang J; Ma P; Liu C; Sun M; Sun Y; He Z
Drug Deliv Transl Res; 2018 Feb; 8(1):64-72. PubMed ID: 29181834
[TBL] [Abstract][Full Text] [Related]
20. [Stability testing of meloxicam-containing microcomposites for inhalation].
Pomázi A; Ambrus R; Szabóné Révész P
Acta Pharm Hung; 2014; 84(2):55-62. PubMed ID: 25167700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
